No Prescription |
 |
 | ||
|
ZYRTEC Generic Cetirizine |
|
| ||
No Prescription » Prescription Drugs 17 » ZYRTEC Generic Cetirizine Zyrtec is an antihistamine. It is prescribed to treat the sneezing; itchy runny nose; and itchy red watery eyes caused by seasonal allergies such as hay fever. Zyrtec also relieves the symptoms of year-round allergies due to dust mold and animal Dander.Preventing or treating symptoms of hay fever and other upper respiratory allergies such as stuffy nose runny nose sneezing itching of the nose and throat and itchy watery eyes. It is also used for preventing or treating chronic hives. Cetirizine is an antihistamine. It works by blocking the action of histamine and reduces the symptoms of an allergic reaction. Buy ZYRTEC Generic Cetirizine and other Prescription Drugs 17 products online at Medstore. Buy Online at Medstore - Click Here!
About ZYRTEC Generic Cetirizine: Product Type: Prescription Drugs 17 ZYRTEC ( Generic Cetirizine ) ZYRTEC (Generic Cetirizine) Generic Cetirizine 10mg 100 ( 10 x 10 ) Tabs Generic Cetirizine ZYRTEC
View more Prescription Drugs 17 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
